On this week’s version of InnovationRx, we take a look at a former Wall Avenue analyst’s $4 billion weight problems drug firm, Wegovy’s weight-loss capsule, and extra.
Source link
Independent global reporting with a national perspective.
On this week’s version of InnovationRx, we take a look at a former Wall Avenue analyst’s $4 billion weight problems drug firm, Wegovy’s weight-loss capsule, and extra.
Source link